OncoCyte Corporation (NASDAQ:OCX) Q2 2019 Results Earnings Conference Call August 14, 2019 4:30 PM ET Company Participants Glenn Garmont - IR, LifeSci Advisors Ronald Andrews - CEO, President Al Parker - Chief Operating Officer Mitchell Levine - CFO Tony Kalajian - Chief Accounting Officer Lyndal Hesterberg - Chief Scientific Officer Conference Call Participants Paul Knight - Janney Montgomery Scott Thomas Flaten - Lake Street Capital Markets Bruce Jackson - The Benchmark Company Keay Nakae - Chardan Capita ...